Skip to content

CIK 0000078003

PFE PFIZER INC

Insider trading from SEC Form 4. Last filing Dec 17, 2024.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
2
with a Form 4 at this company

Signals

Open-market buys and sells at PFIZER INC, scored.

No scored open-market trades yet. Grants, exercises and other rows are below.

Congressional trades

25 trades in PFE disclosed by members of Congress under the STOCK Act, the newest 20 shown. All congressional trades.

MemberTypeAssetAmountTradedFiled
Gilbert Ray Cisneros, Jr.
House · D-CA
Partial salePFE
Pfizer, Inc. Common Stock
$1,001 to $15kMar 13, 2026
25 days after the trade
Gilbert Ray Cisneros, Jr.
House · D-CA
PurchasePFE
Pfizer, Inc. Common Stock
$1,001 to $15kFeb 10, 2026
27 days after the trade
J. French Hill
House · R-AR
SalePFE
Pfizer, Inc. Common Stock
$100k to $250kDec 31, 2025
23 days after the trade
Julia Letlow
House · R-LA
PurchasePFE
Pfizer, Inc. Common Stock
$1,001 to $15kJun 17, 2025
210 days after the trade
Gilbert Ray Cisneros, Jr.
House · D-CA
Partial salePFE
Pfizer, Inc. Common Stock
$1,001 to $15kDec 19, 2025
24 days after the trade
Gilbert Ray Cisneros, Jr.
House · D-CA
PurchasePFE
Pfizer, Inc. Common Stock
$1,001 to $15kNov 18, 2025
27 days after the trade
Gilbert Ray Cisneros, Jr.
House · D-CA
Partial salePFE
Pfizer, Inc. Common Stock
$1,001 to $15kAug 5, 2025
38 days after the trade
Lisa C. McClain
House · R-MI
SalePFE
Pfizer, Inc. Common Stock
$1,001 to $15kAug 4, 2025
39 days after the trade
Lisa C. McClain
House · R-MI
PurchasePFE
Pfizer, Inc. Common Stock
$1,001 to $15kJul 16, 2025
28 days after the trade
Josh Gottheimer
House · D-NJ
SalePFE
Pfizer, Inc. Common Stock
$1,001 to $15kJun 3, 2025
43 days after the trade
Gilbert Ray Cisneros, Jr.
House · D-CA
PurchasePFE
Pfizer, Inc. Common Stock
$1,001 to $15kMay 30, 2025
7 days after the trade
Robert P. Bresnahan, Jr.
House · R-PA
PurchasePFE
Pfizer, Inc. Common Stock
$15k to $50kMay 15, 2025
16 days after the trade
Bruce Westerman
House · R-AR
SalePFE
Pfizer, Inc. Common Stock
$1,001 to $15kApr 21, 2025
21 days after the trade
Jefferson Shreve
House · R-IN
SalePFE
Pfizer, Inc. Common Stock
$15k to $50kApr 11, 2025
27 days after the trade
Gilbert Ray Cisneros, Jr.
House · D-CA
PurchasePFE
Pfizer, Inc. Common Stock
$1,001 to $15kApr 29, 2025
7 days after the trade
Robert P. Bresnahan, Jr.
House · R-PA
SalePFE
Pfizer, Inc. Common Stock
$15k to $50kApr 8, 2025
20 days after the trade
Bruce Westerman
House · R-AR
PurchasePFE
Pfizer, Inc. Common Stock
$1,001 to $15kMar 3, 2025
44 days after the trade
Carol D. Miller
House · R-WV
SalePFE
Pfizer, Inc. Common Stock
$1,001 to $15kMar 10, 2025
32 days after the trade
Gilbert Ray Cisneros, Jr.
House · D-CA
SalePFE
Pfizer, Inc. Common Stock
$15k to $50kMar 31, 2025
7 days after the trade
Robert P. Bresnahan, Jr.
House · R-PA
PurchasePFE
Pfizer, Inc. Common Stock
$15k to $50kFeb 25, 2025
30 days after the trade

Transactions

The last 7 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Dec 13, 2024BOURLA ALBERT
Chairman & CEO
AGrant or award
Phantom Stock Units SSPderivative
+21$25.58$537690,626Dec 17, 2024
Nov 29, 2024BOURLA ALBERT
Chairman & CEO
AGrant or award
Phantom Stock Units SSPderivative
+20$26.21$524690,388Dec 2, 2024
Nov 15, 2024BOURLA ALBERT
Chairman & CEO
AGrant or award
Phantom Stock Units SSPderivative
+21$24.80$521691,116Nov 18, 2024
Oct 31, 2024BOURLA ALBERT
Chairman & CEO
AGrant or award
Phantom Stock Units SSPderivative
+19$28.30$538679,129Nov 1, 2024
Oct 15, 2024BOURLA ALBERT
Chairman & CEO
AGrant or award
Phantom Stock Units SSPderivative
+18$29.44$530679,044Oct 16, 2024
Oct 10, 2024Buckley Mortimer J
director
AGrant or award
Phantom Stock Unitsderivative
+3,771$29.34$111k3,771Oct 15, 2024
Oct 10, 2024BOURLA ALBERT
Chairman & CEO
AGrant or award
Phantom Stock Units SSPderivative
+69$29.34$2,024679,059Oct 11, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.